HISAMITSU PHARMACEUTICAL CO., INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,819 JPY | -0.10% |
|
+1.03% | -11.41% |
| 11/04 | Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024 | MT |
| 12/01 | Hisamitsu Pharmaceutical Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Rise | MT |
Chart calendar Hisamitsu Pharmaceutical Co., Inc.
a14995cb9a3a39004f5823c09da443c.HkuY7pL2T0pzex0ropgLRx5uZk_XARq9Oru9ufNv7no.RnjBrefAATIkSHNp79J7PV8UUXuiNGPNF9KJ2KkesUJcM-qKoYQoOQM8WA~cd2c076a0492778c152244fdebaea0f8
Upcoming events on Hisamitsu Pharmaceutical Co., Inc.
Past events on Hisamitsu Pharmaceutical Co., Inc.
| 11/04/2024 | Q4 2024 Earnings Call |
| 11/04/2024 | Q4 2024 Earnings Release |
| 28/02/2024 | Final dividend |
| 11/01/2024 | Q3 2024 Earnings Release |
| 06/10/2023 | Q2 2023 Earnings Release |
| 30/08/2023 | Ex-dividend day for dividende intermédiaire |
| 13/07/2023 | Q1 2023 Earnings Release |
| 25/05/2023 06:30 am | Annual General Meeting |
| 13/04/2023 | Q4 2023 Earnings Release |
| 27/02/2023 | Final dividend |
| 27/02/2023 | Anniversary bonus dividend |
| 12/01/2023 | Q3 2023 Earnings Release |
| 12/10/2022 | Interim 2023 Earnings Release |
| 30/08/2022 | Ex-dividend day for dividende intermédiaire |
| 07/07/2022 | Q1 2023 Earnings Release |
| 07/04/2022 | FY 2022 Earnings Call |
| 07/04/2022 | FY 2022 Earnings Release |
| 25/02/2022 | Ex-dividend day for final dividend |
| 13/01/2022 | Q3 2022 Earnings Release |
| 14/10/2021 | Interim 2022 Earnings Release |
Past dividends on Hisamitsu Pharmaceutical Co., Inc.
| 28/02/2024 | Final Payment 42.5 JPY |
| 30/08/2023 | Interim Payment 42.5 JPY |
| 27/02/2023 | Final Payment 42.25 JPY |
| 30/08/2022 | Interim Payment 42.25 JPY |
| 25/02/2022 | Final Payment 42 JPY |
| 30/08/2021 | Interim Payment 42 JPY |
| 25/02/2021 | Final Payment 41.75 JPY |
| 28/08/2020 | Interim Payment 41.75 JPY |
| 27/02/2020 | Final Payment 41.5 JPY |
| 29/08/2019 | Interim Payment 41.5 JPY |
Annual results
| Fiscal Period | February | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 143 408 142 400 0.71% | 140 992 138 000 2.17% | 114 510 117 500 -2.54% | 120 193 123 000 -2.28% | 128 330 128 000 0.26% | 141 706 142 500 -0.56% |
|
EBITDA Million JPY | Released Forecast Spread | 28 020 28 100 -0.28% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million JPY | Released Forecast Spread | 22 278 22 650 -1.64% | 22 727 23 900 -4.91% | 10 671 12 000 -11.08% | 9 337 9 400 -0.67% | 11 599 12 000 -3.34% | 13 167 15 600 -15.6% |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 25 673 25 900 -0.88% | 26 155 27 900 -6.25% | 12 197 13 300 -8.29% | 12 956 12 600 2.83% | 16 113 17 300 -6.86% | 19 186 21 000 -8.64% |
|
Net income Million JPY | Released Forecast Spread | 19 204 18 900 1.61% | 18 694 21 300 -12.23% | 9 250 9 300 -0.54% | 9 658 8 800 9.75% | 11 742 12 900 -8.98% | 13 969 15 300 -8.7% |
|
EPS JPY | Released Forecast Spread | 230 217 6.06% | 228 261 -12.75% | 113 114 -0.51% | 119 110 7.82% | 148 164 -9.64% | 182 199 -8.9% |
| Announcement Date | 10/04/19 | 10/04/20 | 08/04/21 | 07/04/22 | 13/04/23 | 11/04/24 |
Quarterly results
| Fiscal Period | February | 2020 S1 | 2021 S1 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 S1 | 2023 Q3 | 2024 Q1 | 2024 S1 | 2024 Q3 | 2025 Q1 | 2025 S1 | 2026 S1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 63 401 66 500 -4.66% | 52 926 55 000 -3.77% | 58 551 60 000 -2.42% | 28 112 | 26 393 29 000 -8.99% | 59 619 60 000 -0.64% | 32 262 | 32 096 31 000 3.54% | 66 977 66 000 1.48% | 35 850 | 36 500 | 74 000 | 76 500 |
|
EBIT Million JPY | Released Forecast Spread | 10 190 9 800 3.98% | 5 516 6 100 -9.57% | 5 706 5 900 -3.29% | 1 267 | 519 2 300 -77.43% | 4 913 4 700 4.53% | 3 593 | 4 361 1 900 129.53% | 8 396 8 200 2.39% | 3 874 | 3 400 | 7 400 | 8 700 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 10 637 10 700 -0.59% | 5 515 6 350 -13.15% | 7 168 6 800 5.41% | 1 824 | 2 398 2 700 -11.19% | 8 935 | 4 094 | 5 712 | 11 638 | 5 021 | 4 000 | 9 200 | 10 500 |
|
Net income Million JPY | Released Forecast Spread | 7 548 8 100 -6.81% | 3 693 4 150 -11.01% | 5 002 5 100 -1.92% | 1 216 | 1 631 1 900 -14.16% | 6 504 5 100 27.53% | 3 018 | 4 049 1 500 169.93% | 8 417 7 100 18.55% | 3 693 | 3 300 | 7 500 | 7 600 |
|
EPS JPY | Released Forecast Spread | 91,4 99,2 -7.89% | 45,2 51,5 -12.19% | 61,2 62,4 -1.92% | 14,9 | 20,5 22,2 -7.84% | 81,6 64,9 25.7% | 37,9 | 52,1 19,4 168.51% | 108 92,5 17.12% | 48,3 | 43,6 | 91,3 | 93,0 |
| Announcement Date | 10/10/19 | 08/10/20 | 14/10/21 | 13/01/22 | 07/07/22 | 12/10/22 | 12/01/23 | 13/07/23 | 06/10/23 | 11/01/24 | - | - | - |
| Today 01:35 am | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| Today 01:35 am | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 02/05/2024 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| 02/05/2024 | AMGEN INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:00 am | NOVO NORDISK A/S: Q1 2024 Earnings Release |
| 02/05/2024 05:00 pm | ORGANON & CO.: Q1 2024 Earnings Release |
| 03/05/2024 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
| 03/05/2024 | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
| 03/05/2024 | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
| 03/05/2024 | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
Past sector events for Hisamitsu Pharmaceutical Co., Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4530 Stock
- Calendar Hisamitsu Pharmaceutical Co., Inc.
